profit from every $100 of sales.
$0$100
The Beauty Health
$16.31+2.19% today
-37.3% in 1 year
1-year low $9.941-year high $31.80
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What The Beauty Health sold, what it kept, and what it did with the cash.
Sales went from $366 million in 2022 to $301 million in 2025, with -$9.52 million of profit last year.
SalesProfit
The Beauty Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| The Beauty Health | No profit yet | ||
 Procter & Gamble | 24.5× · Fair price | ||
 L'Oréal | 39.3× · Expensive | ||
 Unilever | 13.7× · Cheap | ||
 Colgate-Palmolive | 37.2× · Expensive |
AI analysis
An AI analyst reads The Beauty Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 366 | 398 | 334 | 301 | |
| 249 | 155 | 182 | 196 | |
| -26 | -131 | -68 | -21 | |
| 82 | -54 | 15 | 39 | |
| 44 | -100 | -29 | -10 | |
| 0.23 | -0.76 | -0.23 | -0.16 | |
| 68.0% | 39.0% | 54.5% | 65.3% | |
| -7.1% | -32.9% | -20.3% | -6.9% | |
| 12.1% | -25.2% | -8.7% | -3.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,003 | 929 | 686 | 500 |
| Cash | 568 | 523 | 370 | 233 |
| Total debt | 752 | 752 | 568 | 379 |
| Total liabilities | 836 | 870 | 634 | 439 |
| 167 | 59 | 52 | 61 | |
| 149 | 132 | 124 | 136 | |
| 5.0% | -8.6% | -2.4% | 2.4% | |
| 26.5% | -168.6% | -56.2% | -15.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -107 | 22 | 16 | 37 | |
| 17 | 13 | 7 | 5 | |
| -124 | 9 | 9 | 32 | |
| Dividends paid | – | – | – | – |
| 160 | 32 | 0 | 0 | |
| 28 | 23 | 27 | 15 |
Valuation
- –
- –
- –
- 1.6×
- 0.4×
- 3.3×
- 6.5×
- 30.4%
- -9.0%
- 0.0%
Profitability
- 65.3%
- -6.9%
- -3.2%
- 14.5%
- -2.5%
- -10.1%
- -9.4%
- -1.3%
- -3.3%
- 1.9%
Growth
- −6.3%
- –
- +298.1%
- –
- +5.5%
Financial health
- 3.8×
- 6.65
- 77.6%
- -0.5×
- 1.79
- 1.48
- 0.63
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 4%of 669
Bottom 1%of 672
Bottom 4%of 671
Top 1%of 666
What analysts expect
- Average price target
- $1.30
- Range
- $1.00 – $1.60
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | -0.05 | -0.09 | +44.4% |
| Mar 12, 2026 | -0.06 | -0.07 | +14.3% |
| Nov 6, 2025 | -0.09 | -0.08 | −12.5% |
| Aug 7, 2025 | 0.03 | -0.06 | +150.0% |
| May 8, 2025 | -0.08 | -0.13 | +38.5% |
| Mar 12, 2025 | -0.08 | -0.10 | +20.0% |
| Nov 12, 2024 | -0.15 | -0.12 | −25.0% |
| Aug 8, 2024 | -0.10 | -0.05 | −100.0% |
News
Sally Beauty Non-GAAP EPS of $0.62 beats by $0.02, revenue of $952.5M beats by $2.42M, issues FY guidance above consensusSeeking Alpha · Nov 10, 2026Ulta Beauty tops consumer discretionary gainers in Q3; MGM Resorts declinesSeeking Alpha · Oct 4, 2026Beauty, health and wellness are converging into one retail categoryCNBC · Sep 18, 2026K-beauty giant APR's shares up 100% this year ahead of U.S. Costco launch in SeptemberCNBC · Aug 30, 2026Ulta Beauty Stock Is Down Today. Now Could Be a Good Time to Buy.Yahoo Finance · Aug 28, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
32No pass
Benjamin Graham
31No pass
Philip Fisher
33No pass
Peter Lynch
4No pass
Joel Greenblatt
20No pass
Charlie Munger
19No pass
Terry Smith
18No pass
Questions about The Beauty Health
Is The Beauty Health a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the The Beauty Health AI analysis
What does The Beauty Health do?
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. It is in Household & Personal Products.
Does The Beauty Health pay a dividend?
No. The Beauty Health does not pay a dividend at the moment.
Is The Beauty Health stock halal?
No. The Beauty Health does not pass our halal screen: its debt is 356% of its market value, at or above the 33% limit. How we check
How has The Beauty Health stock done over the past year?
Down 37.3% over the past twelve months, to $16.31. It traded between $9.94 and $31.80 and is 48.7% below its high.
Who are The Beauty Health's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with The Beauty Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.